Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Elisabeth G Celius, Heidi Thompson, Maija Pontaga, Dawn Langdon, Alice Laroni, Stanca Potra, Trishna Bharadia, David Yeandle, Jane Shanahan, Pieter van Galen, Nektaria Alexandri & Jürg Kesselring. (2021) Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives. Patient Preference and Adherence 15, pages 15-27.
Read now
Read now
Kendra L Furber, Marina Van Agten, Charity Evans, Azita Haddadi, J Ronald Doucette & Adil J Nazarali. (2017) Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a. Degenerative Neurological and Neuromuscular Disease 7, pages 47-60.
Read now
Read now
José Manuel Garcia-Dominguez, Delicias Muñoz, Marta Comellas, Irmina Gonzalbo, Luis Lizán & Carlos Polanco Sánchez. (2016) Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment. Patient Preference and Adherence 10, pages 1945-1956.
Read now
Read now
Leo H Visser, Marco A Heerings, Peter J Jongen & Karin van der Hiele. (2016) Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment. Patient Preference and Adherence 10, pages 659-667.
Read now
Read now
Jennifer Smrtka, Theodore Brown & Greg Bjorklund. (2016) Loss of mobility and the patient burden of multiple sclerosis: expert opinion on relevance to daily clinical practice. Postgraduate Medicine 128:1, pages 145-151.
Read now
Read now
Danny Decoo & Mathieu Vokaer. (2015) Treatment adherence in multiple sclerosis: a survey of Belgian neurologists. Patient Preference and Adherence 9, pages 1669-1676.
Read now
Read now
Sander Yermakov, Matthew Davis, Michaela Calnan, Monica Fay, Brieana Cox-Buckley, Sujata Sarda, Mei Sheng Duh & Ravi Iyer. (2015) Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis. Journal of Medical Economics 18:9, pages 711-720.
Read now
Read now
Mehmood Syed, David Rog, Laura Parkes & Gillian L Shepherd. (2014) Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practice. Patient Preference and Adherence 8, pages 247-255.
Read now
Read now
Alessandra Lugaresi, Tjalf Ziemssen, Celia Oreja-Guevara, Delyth Thomas & Elisabetta Verdun. (2012) Improving patient–physician dialog: commentary on the results of the MS Choices survey. Patient Preference and Adherence 6, pages 143-152.
Read now
Read now
Articles from other publishers (1)
Robert J. Fox, Rina Mehta, Timothy Pham, Julie Park, Kathleen Wilson & Machaon Bonafede. (2022) Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis. BMC Neurology 22:1.
Crossref
Crossref